1 story in the last 7 days
The latest immix news, distilled by AI into sharp ~100-word summaries. ByteBrief tracks immix across dozens of tech sources and brings you only what matters, updated hourly. Tap any story for the full brief, or open the original source.

AbbVie's Humira contributes nearly half of its profits; the company's acquisition of Allergan adds drugs in women's health and aesthetics. Johnson & Johnson's drug and device segments account for 80% of sales and drive most cash flow. The company's drug focus includes immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Immix Biopharma has a market cap of $570.
Summaries by ByteBrief